Advertisement Healogix appoints Tim Edbrooke as new president - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Healogix appoints Tim Edbrooke as new president

Healogix has appointed Tim Edbrooke as the company's new president and chief operating officer (COO).

In 2009, Edbrooke joined Healogix as chief business officer where he led the company through the most significant growth phase.

Previously joining to Healogix, Edbrooke was the chief executive officer (CEO) of Genactis, a strategic research-based company.

He also held various executive and business development positions within pharmaceutical research and services firms including TVG, GfK Healthcare and Quintiles Transnational.

Healogix CEO Harris Kaplan said Tim’s appointment to the presidency is a reflection of the confidence that he and all have in Tim’s ability to build on their success to-date and make them even more successful in the future.

Healogix president and COO Tim Edbrooke said they have seen increasing industry demand for their solutions as biopharmaceutical companies look for ways to best position and target their products for increased market share.

"I’m looking forward to continuing to work with the team we’ve assembled to lead us into another year of growth and advancement," Edbrooke said.